PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial - Borchmann, P; Plütschow, A; Kobe, C (The Lancet Oncology, 2021)